Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Contemporary Clinical Trials
|
May 31, 2024
Functional outcomes of diets in multiple sclerosis (FOOD for MS): Protocol for a parallel arm randomized feeding trial for low glycemic load and calorie restriction
Kat Martin, Stacey S Cofield, Anne H Cross, et al.
Science Translational Medicine
|
July 20, 2022
Miswiring of Merkel cell and pruriceptive C fiber drives the itch-scratch cycle
Jing Feng, Yonghui Zhao, Zili Xie, et al.
JAMA Oncology
|
September 1, 2022
Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity Syndrome
Omar H Butt, Alice Y Zhou, Paolo F Caimi, et al.
Multiple Sclerosis and Related Disorders
|
June 25, 2023
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial
Mitzi J Williams, Annette F Okai, Anne H Cross, et al.
The Journal of Clinical Investigation
|
January 26, 2023
A TRPV4-dependent neuroimmune axis in the spinal cord promotes neuropathic pain
Xueming Hu, Lixia Du, Shenbin Liu, et al.
Nature
|
August 14, 2020
cDC1 prime and are licensed by CD4<sup>+</sup> T cells to induce anti-tumour immunity
Stephen T Ferris, Vivek Durai, Renee Wu, et al.
The Journal of Clinical Investigation
|
January 2, 2025
A single-cell compendium of human cerebrospinal fluid identifies disease-associated immune cell populations
Claudia Cantoni, Roman A Smirnov, Maria Firulyova, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 16, 2026
Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple Sclerosis
Roman A Smirnov, Claudia Cantoni, Kenneth Lee, et al.
Med (New York, N.Y.)
|
November 23, 2021
Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors
Rita E Chen, Matthew J Gorman, Daniel Y Zhu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 13, 2024
Randomised controlled trial of intermittent calorie restriction in people with multiple sclerosis
Laura Ghezzi, Valeria Tosti, Lisa Shi, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Contemporary Clinical Trials
|
May 31, 2024
Functional outcomes of diets in multiple sclerosis (FOOD for MS): Protocol for a parallel arm randomized feeding trial for low glycemic load and calorie restriction
Kat Martin, Stacey S Cofield, Anne H Cross, et al.
Science Translational Medicine
|
July 20, 2022
Miswiring of Merkel cell and pruriceptive C fiber drives the itch-scratch cycle
Jing Feng, Yonghui Zhao, Zili Xie, et al.
JAMA Oncology
|
September 1, 2022
Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell-Associated Neurotoxicity Syndrome
Omar H Butt, Alice Y Zhou, Paolo F Caimi, et al.
Multiple Sclerosis and Related Disorders
|
June 25, 2023
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial
Mitzi J Williams, Annette F Okai, Anne H Cross, et al.
The Journal of Clinical Investigation
|
January 26, 2023
A TRPV4-dependent neuroimmune axis in the spinal cord promotes neuropathic pain
Xueming Hu, Lixia Du, Shenbin Liu, et al.
Nature
|
August 14, 2020
cDC1 prime and are licensed by CD4<sup>+</sup> T cells to induce anti-tumour immunity
Stephen T Ferris, Vivek Durai, Renee Wu, et al.
The Journal of Clinical Investigation
|
January 2, 2025
A single-cell compendium of human cerebrospinal fluid identifies disease-associated immune cell populations
Claudia Cantoni, Roman A Smirnov, Maria Firulyova, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
April 16, 2026
Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple Sclerosis
Roman A Smirnov, Claudia Cantoni, Kenneth Lee, et al.
Med (New York, N.Y.)
|
November 23, 2021
Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors
Rita E Chen, Matthew J Gorman, Daniel Y Zhu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
August 13, 2024
Randomised controlled trial of intermittent calorie restriction in people with multiple sclerosis
Laura Ghezzi, Valeria Tosti, Lisa Shi, et al.
Page
of 8